A phase I study of concomitant CPT-11 (C) and 5FU (F) combination: Preliminary results

被引：0
|
作者：
Rixe, O
Benhammouda, A
Farabos, C
Borel, C
Petit, T
Auclerc, G
Coeffic, D
Bastian, G
Grossin, F
Paraiso, D
Grapin, JP
Nizri, D
Weil, M
Bismuth, H
Mahjoubi, M
Khayat, D
机构：
[1] SALPETRIERE HOSP,SOMPS,PARIS,FRANCE
[2] HOP PAUL BROUSSE,VILLEJUIF,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：955 / 955
页数：2
相关论文
共 50 条
  • [1] Phase I/II study of irinotecan (CPT-11) combined with 1-leucovorin (I-LV) and 5FU in patients with advanced colorectal cancer
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 437 - 437
  • [2] A randomized phase III trial of adjuvant radio - Chemotherapy comparing irinotecan (CPT-11), 5FU and leucovorin to 5FU and leucovorin in patients with rectal cancer
    Kalofonos, Haralabos P.
    Pentheroudakis, George
    Rigatos, Sotirios
    Papakostas, Pavlos
    Tsavdaridis, Dimitrios
    Xiros, Nikolaos
    Dimopoulos, Meletios A.
    Galani, Eleni
    Pectasides, Dimitrios
    Fountzilas, George
    ANNALS OF ONCOLOGY, 2006, 17 : 116 - 116
  • [3] Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma - A phase III randomized study
    Tsavaris, Nicolas
    Kosmas, Christos
    Skopelitis, Helias
    Papadoniou, Nicitas
    Polyzos, Aristidis
    Zografos, George
    Adoniou, Efstathios
    Gryniatsos, John
    Felekouras, Evangelos
    Zacharakis, Michalis
    Sigala, Francheska
    Bacoyiannis, Christos
    Papastratis, George
    Papalambros, Efstathios
    CHEMOTHERAPY, 2007, 53 (04) : 282 - 291
  • [4] 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) versus CPT-11 followed by 5-FU/LV at relapse in patients with advanced colorectal carcinoma. Phase III randomized study
    Tsavaris, N.
    Kosmas, C.
    Skopelitis, E.
    Papadoniou, N.
    Polyzos, A.
    Zografos, G.
    Diamartis, N.
    Ntokou, A.
    Tsaousi, S.
    Sarantonis, I
    Adoniou, E.
    Gryniatsos, J.
    Felekouras, E.
    Papalambros, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 81 - 81
  • [5] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [6] Preoperative concomitant radiotherapy and chemotherapy with CPT-11 and 5-FU in locally advanced rectal cancer.: Results of a phase II study
    Hervás, A
    Cambray, M
    Cardenal, A
    Carbrera, A
    Hernandez, A
    Reig, A
    Rodriguez, M
    García, A
    Asensio, D
    Navarro, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S265 - S265
  • [7] Phase I/II study of CPT-11 in combination with LV2FU5 (De Gramont-Regimen) every 2 weeks for the treatment of colorectal cancer (CRC) after 5FU failure
    Rougier, P
    Ychou, M
    Seitz, JF
    Bonnay, M
    Mignard, D
    Couteau, C
    Armand, JP
    Ducreux, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 756 - 756
  • [8] A multicenter phase II study of irinotecan (CPT-11) and bolus 5-fluorouracil (5FU)/I-leucovorin (I-LV) in patients with metastatic colorectal cancer
    Fujishima, H
    Makiyama, A
    Miyanaga, O
    Ueda, A
    Esaki, T
    Mitsugi, K
    Baba, E
    Kusaba, H
    Harada, M
    Nakano, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 306S - 306S
  • [9] CPT-11 and L-OHP combination versus alternated combination of LV5FU2+CPT-11/LV5FU2+L-OHP in 5-FU resistant advanced colorectal cancer (CRC): Preliminary results
    Becouam, Y
    Mousseau, M
    Gamelin, E
    Coudert, B
    Marceau-Suissa, J
    Bekradda, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S71 - S71
  • [10] A PHASE-I STUDY OF CPT-11, WEEKLY BOLUS 5-FU AND LEUCOVORIN IN PATIENTS WITH METASTATIC CANCER
    PARNES, HL
    TAIT, N
    CONLEY, B
    VANECHO, D
    ONCOLOGY REPORTS, 1995, 2 (06) : 1131 - 1134
12345